* Dynavax Technologies Corp DVAX.OQ reported quarterly
adjusted
earnings of 8 cents per share for the quarter ended in June,
higher than the same quarter last year, when the company
reported EPS of 3 cents. The mean expectation of five analysts
for the quarter was for earnings of 6 cents per share. Wall
Street expected results to range from 3 cents to 10 cents per
share.
* Revenue rose 22.5% to $73.80 million from a year ago;
analysts
expected $76.10 million.
* Dynavax Technologies Corp's reported EPS for the quarter
was 8
cents.
* The company reported quarterly net income of $11.39
million.
* Dynavax Technologies Corp shares had fallen by 10.3% this
quarter and lost 28.0% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had fallen by
about 26.2%
in the last three months.
* In the last 30 days, one analyst negatively revised an
earnings
estimate
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"
Wall Street's median 12-month price target for Dynavax
Technologies Corp is $27.00
This summary was machine generated from LSEG data August 6 at
10:17 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Jun. 30 2024 0.06 0.08 Beat
Mar. 31 2024 -0.02 -0.07 Missed
Dec. 31 2023 -0.01 0.00 Beat
Sep. 30 2023 -0.01 0.10 Beat